[Skip to Content]
[Skip to Content Landing]
December 1986

Fatal Disseminated Infection due to Poliovirus Type 2 Vaccine

Author Affiliations

Departments of Anesthesiology and Pediatrics
Department of Pediatrics University of Texas Health Science Center 7703 Floyd Curl Dr San Antonio, TX 78284

Am J Dis Child. 1986;140(12):1211-1212. doi:10.1001/archpedi.1986.02140260013004

Sir.—Central nervous system disease secondary to vaccine poliovirus infection is a well-documented phenomenon both in immunocompromised children and in the normal host.1,2 Myocarditis and pneumonitis have not been previously reported as a consequence of vaccinelike strains, to our knowledge, and a diffuse encephalomyelitis is rare. We herein describe a 5-month-old infant who developed multiple organ dysfunction secondary to infection by vaccine poliovirus type 2 acquired by household exposure.

Report of a Case.—A 5-month-old male infant presented with failure to thrive and respiratory distress after receiving a regimen of nasal betamethasone dipropionate, 1 mg/d, for three months, which had been prescribed by a local physician for nasal congestion. Recurrent bilateral otitis media, oral thrush, and a monilial rash had become persistent problems. A temperature of 40.6°C accompanied by marked respiratory distress necessitated admission to our hospital. Significant history included the fact that two family members, both children, had

First Page Preview View Large
First page PDF preview
First page PDF preview